tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

DSGN Stock Latest News

Design Therapeutics reports Q1 EPS (20c), consensus (26c)
The FlyDesign Therapeutics reports Q1 EPS (20c), consensus (26c)
2M ago
DSGN
Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
PremiumPress Releases
Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
2M ago
DSGN
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
PremiumPress Releases
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
2M ago
DSGN
Design Therapeutics upgraded to Overweight from Neutral at Piper Sandler
PremiumThe Fly
Design Therapeutics upgraded to Overweight from Neutral at Piper Sandler
2M ago
DSGN
Is DSGN a Buy, Before Earnings?
PremiumPre-Earnings
Is DSGN a Buy, Before Earnings?
2M ago
DSGN
Design Therapeutics management to meet with Piper Sandler
PremiumThe FlyDesign Therapeutics management to meet with Piper Sandler
3M ago
DSGN
Design Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Design Therapeutics management to meet with Piper Sandler
3M ago
DSGN
Design Therapeutics, Inc.: Navigating Liquidity Risks Amidst Bank Failures
PremiumCompany Announcements
Design Therapeutics, Inc.: Navigating Liquidity Risks Amidst Bank Failures
4M ago
DSGN
Design Therapeutics reports Q4 EPS (21c), consensus (31c)
PremiumThe Fly
Design Therapeutics reports Q4 EPS (21c), consensus (31c)
4M ago
DSGN
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
4M ago
DSGN
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
PremiumPress Releases
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
4M ago
DSGN
Design Therapeutics, Inc. (DSGN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Design Therapeutics, Inc. (DSGN) Q4 Earnings Cheat Sheet
4M ago
DSGN
Design Therapeutics cut to Neutral at Piper on limited near-term news flow
PremiumThe FlyDesign Therapeutics cut to Neutral at Piper on limited near-term news flow
8M ago
DSGN
Design Therapeutics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Design Therapeutics downgraded to Neutral from Overweight at Piper Sandler
8M ago
DSGN
Design Therapeutics price target lowered to $4 from $7 at RBC Capital
PremiumThe Fly
Design Therapeutics price target lowered to $4 from $7 at RBC Capital
8M ago
DSGN
Design Therapeutics reports Q3 EPS (28c), consensus (41c)
PremiumThe Fly
Design Therapeutics reports Q3 EPS (28c), consensus (41c)
8M ago
DSGN
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
PremiumPress Releases
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
8M ago
DSGN
Multiple Downgrades Send Design Therapeutics (NASDAQ:DSGN) Down in Flames
PremiumMarket News
Multiple Downgrades Send Design Therapeutics (NASDAQ:DSGN) Down in Flames
11M ago
DSGN
Redfin upgraded, CSSE downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Redfin upgraded, CSSE downgraded: Wall Street’s top analyst calls
11M ago
HXL
ODD
Design Therapeutics downgraded to Market Perform at SVB Securities
PremiumThe FlyDesign Therapeutics downgraded to Market Perform at SVB Securities
11M ago
DSGN
Wedbush downgrades Design Therapeutics to Neutral, cuts price target to $6
PremiumThe Fly
Wedbush downgrades Design Therapeutics to Neutral, cuts price target to $6
11M ago
DSGN
RBC cuts Design Therapeutics to Sector Perform, sees DT-216 data fall short
PremiumThe Fly
RBC cuts Design Therapeutics to Sector Perform, sees DT-216 data fall short
11M ago
DSGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >